Format

Send to:

Choose Destination
See comment in PubMed Commons below
Nat Rev Cancer. 2001 Nov;1(2):118-29.

Improving the efficacy of antibody-based cancer therapies.

Author information

  • 1Immunex, Seattle, Washington 98101, USA. carterp@immunex.com

Abstract

A quarter of a century after their advent, monoclonal antibodies have become the most rapidly expanding class of pharmaceuticals for treating a wide variety of human diseases, including cancer. Although antibodies have yet to achieve the ultimate goal of curing cancer, many innovative approaches stand poised to improve the efficacy of antibody-based therapies.

PMID:
11905803
[PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group
    Loading ...
    Write to the Help Desk